Emerging Therapies in Heart Failure Management
Heart failure is a significant global health challenge, affecting millions of people worldwide. It arises from various causes, including ischemic heart disease, hypertension, valvular abnormalities, and cardiomyopathies. The primary issue in heart failure is the heart's inability to efficiently pump blood, leading to debilitating symptoms and high mortality rates. Traditional management has focused on alleviating symptoms and enhancing cardiac function through medications and device-based interventions. Despite the progress in conventional treatments, heart failure continues to be a clinical challenge due to complex underlying mechanisms such as neurohormonal activation, cardiac fibrosis, and cellular remodeling. Several emerging therapies could address these challenges. Gene therapy , including gene-editing techniques like CRISPR-Cas9, for correcting genetic mutations contributing to heart failure, offers a promising avenue for addressing the root causes of this condition.